SCHEMBL29888780

SCHEMBL29888780

Clc1nc(-c2ccccc2)nc2c1sc1ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ LMNA P02545 2/20 0.42
▸ TNKS O95271 3/20 0.40
▸ TNKS2 Q9H2K2 3/20 0.40
▸ LIMK1 P53667 1/20 0.40
▸ CDK5 Q00535 1/20 0.40
▸ CDK5R1 Q15078 1/20 0.40
▸ MAPT P10636 3/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ PIM1 P11309 1/20 0.37
▸ PIM2 Q9P1W9 1/20 0.37
▸ KRAS P01116 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ HRH4 Q9H3N8 1/20 0.36
▸ EGLN1 Q9GZT9 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ PDE5A O76074 2/20 0.35
▸ ABCG2 Q9UNQ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17022477 1.00 MEN1 (0.46) MEN1HTTKMT2ALMNATNKS
SCHEMBL26266691 0.97 MEN1 (0.44) MEN1HTTKMT2ALMNATNKS
SCHEMBL18666124 0.90 LIMK1 (0.39) MEN1HTTKMT2ALMNATNKS
SCHEMBL18553250 0.88 LIMK1 (0.40) MEN1HTTKMT2ALMNATNKS
SCHEMBL20659731 0.87 PRKCI (0.42) MEN1KMT2ATNKSTNKS2LIMK1
SCHEMBL20669909 0.84 KDM4E (0.39) MEN1HTTKMT2ATNKSTNKS2
SCHEMBL30333314 0.83 MEN1 (0.43) MEN1KMT2ALMNATNKSTNKS2
SCHEMBL18370214 0.83 MEN1 (0.43) MEN1KMT2ALMNATNKSTNKS2
SCHEMBL30775145 0.81 DPP4 (0.46) MEN1KMT2ALMNATNKSTNKS2
SCHEMBL19136191 0.81 DPP4 (0.46) MEN1KMT2ALMNATNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12419192-B2 Organic electroluminescence devices MERCK PATENT GMBH (DE) 2025-09-16 — — US disclosed
EP-3803998-B1 ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2025-07-30 — — EP disclosed
EP-3519415-B1 CARBAZOLES WITH DIAZADIBENZOFURANE OR DIAZADIBENZOTHIOPHENE STRUCTURES MERCK PATENT GMBH (DE) 2022-12-14 — — EP disclosed
US-20220336754-A1 ORGANIC ELECTROLUMINESCENCE DEVICES MERCK PATENT GMBH (DE) 2022-10-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12419192-B2 Organic electroluminescence devices NDUFS3, NDUFS2, NDUFS5 MEN1 3190/4885HTT 1228/4885KMT2A 3391/4885
US-20220336754-A1 ORGANIC ELECTROLUMINESCENCE DEVICES NDUFS3, NDUFS2, NDUFS5 MEN1 3190/4885HTT 1228/4885KMT2A 3391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback